News on companies and Gilead Sciences
Analyze the latest news on companies and Gilead Sciences, extract the entire dataset or get visualizations.
Related dashboards:
- Gilead Sciences (organization)
- Gilead Sciences (organization)
Latest news
Stocks making the biggest moves midday: Boeing, Nvidia, Autodesk, Gilead Sciences and more
Stocks making the biggest moves premarket: General Mills, Gilead Sciences, Tesla and more
Boeing, Nvidia, Tesla, BYD, Tencent, Gilead, General Mills, Autodesk: Stocks in view today
Gilead's new HIV med, a bird flu shot for chickens, and Hims does blood tests: Pharma news roundup
Gilead Agrees to Allow Generic Version of Groundbreaking H.I.V. Shot in Poor Countries
Dr Reddy's, Hetero ink royalty-free voluntary licencing pacts with Gilead Sciences for HIV drug Lenacapavir
Gilead Sciences alleges dangerous drug-counterfeiting operation at two NYC pharmacies in lawsuit
Stocks making the biggest moves premarket: Gilead Sciences, Sarepta Therapeutics, Nike and more
Stocks making the biggest moves midday: Gilead Sciences, Accenture, Trump Media, AMD and more
CymaBay shares jumped nearly 25% to hit a record after the clinical-stage biopharmaceutical company agreed to be acquired by Gilead for $4.3 billion.
CymaBay Therapeutics Shares Hit All-Time High on Gilead Deal
CymaBay Therapeutics Shares Hit All-Time High on Gilead Deal
Stocks making the biggest moves midday: Vita Coco, Archer-Daniels-Midland, Gilead Sciences and more
Extract data
Extract all the news on this scope:
Visualize data
Trend on this scope:
Evolution through time
Source analysis:
Distribution of sources in the news
Section analysis:
Distribution of sections in the news
Current sentiment polarity: neutral (0.21)
neutral | 59% | |
positive | 32% | |
negative | 9% |
Sentiment polarity through time